# BME100 s2015:Group11 12pmL2

BME 100 Spring 2015 | Home People Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3 Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6 Course Logistics For Instructors Photos Wiki Editing Help
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

## OUR TEAM## LAB 2 WRITE-UP## Descriptive Statistics
Average Inflammotin Concentration in Human Groups:
Average Inflammotin Concentration in Rat Groups:
## Results
## Analysis
Variance in Human Groups
Single Factor ANOVA for Human Groups
Bonferroni Correction for ANOVA in Human Groups
The ANOVA test is run on the human group due to the fact that there are four different doses of LPS, and therefore four different groups between which the differences are being investigated.
T-Test Value for Rat Group: 0.867403497 P-Value for Rat Group: 0.545129 Significance? No. 0.545129>0.05 The T-test is run on the rat group since differences are only being examined between two groups.
## Summary/DiscussionAccording to the p-value for experiment 1, there is a significant difference among the four doses of LPS in humans because the variance in error does not overlap in each dose on the bar graph. In the Bonferroni correction the comparison between all groups showed significance when comparing the t-test values to the corrected p-value because the t-values were less than the p-values. This means the dose of LPS present in the elderly, does make a difference in the amount of inflammotin in elderly. In experiment 2, there was no significant difference between the doses of LPS in the rats because the p-value obtained from the t-test was greater than the acceptable p-value of 0.05. This means the doses of LPS does not make a significant difference in the amount of inflammotin produced in rats. The link from the two experiments is that the different doses of LPS does make a difference in the humans’ production of inflammotin, as recorded among several groups, while LPS contributes no effect to the rat’s ability to produce inflammotin. |